CTSO Earnings

Quarterly EPS
$-0.05
Q3 2024
$-0.15
Q4 2024
$-0.02
Q1 2025
$0.03
Q2 2025
$-0.05
Q3 2025
$-0.09
Q4 2025
$-0.08
Q1 2026
$-0.07
Q2 2026
Latest Revenue9.6M
Latest Net Income-4417000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.079.6M-4417000+0.2%-333.3%
Q1 2026-$0.088.9M-5129000+1.6%-300.0%
Q4 2025-$0.099.2M-5497000+0.9%+40.0%
Q3 2025-$0.059.5M-3170000+10.1%+0.0%
Q2 2025$0.039.6M1.9M+8.8%+137.5%
Q1 2025-$0.028.7M-1479000-2.9%+81.8%
Q4 2024-$0.159.2M-7567000+168.8%-7.1%
Q3 2024-$0.058.6M-2768000-2.2%+76.2%
Q2 2024-$0.088.8M-4294000
Q1 2024-$0.119.0M-6088711
Q4 2023-$0.143.4M-6574273
Q3 2023-$0.218.8M-9193520
Cytosorbents (CTSO) — Earnings